Abiopharma

Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI® (lecanemab)

argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG

[Press Release] HUTCHMED Announces Appointment of Acting Chief Executive Officer

Ceasing to be a substantial holder

Q & M Dental Group (Singapore) Limited - Announcement

PhillipCapital’s Equity Research – Bump in the Road, Scaling Up Journey Intact

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Xylo Technologies Ltd. - American Depositary Shares.

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Xylo Technologies Ltd. - American Depositary Shares.

NASDAQ traded attribute type Security_Name was changed. Previous value: Xylo Technologies Ltd. - American Depositary Shares. New value: Xylo Technologies Ltd. - American Depositary Shares.

HUTCHMED Announces Appointment of Acting Chief Executive Officer

LNTH Investors Have Opportunity to Join Lantheus Holdings, Inc. Fraud Investigation with the Schall Law Firm

SRTS Investors Have Opportunity to Join Sensus Healthcare, Inc. Fraud Investigation with the Schall Law Firm

The Best Mini PCs for Gaming

Best Bose Soundbar Models (2025)

Best Curved Gaming Monitors in 2025